Can a drug stop Alzheimer’s before it starts? Penn is part of an international trial for people aging without symptoms.
People in the trial have abnormal proteins in their brains, but they have yet to see any decline in cognitive ability.
Skip to contentTony Kenneff, 71, of Manheim, Pa., receives an infusion at Penn's Perelman Center for Advanced Medicine.